42 JOURNAL OF CHEMICAL RESEARCH 2018
(td, J = 7.5, 1.3 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 7.25 (dd, J = 7.8, 0.7
Hz, 1H), 7.15–7.03 (m, 2H), 7.05–6.93 (m, 2H), 4.57 (dd, J = 8.1, 3.9
Hz, 1H), 3.23 (dd, J = 19.2, 8.1 Hz, 1H), 2.63 (dd, J = 19.2, 3.9 Hz, 1H);
13C NMR (100 MHz, CDCl3): δ 205.7, 161.8 (d, J = 245.5 Hz), 157.7,
139.5 (d, J = 3.3 Hz), 136.8, 135.2, 129.2 (d, J = 8.1 Hz), 128.1, 126.8,
123.5, 115.8 (d, J = 21.3 Hz), 46.9 (d, J = 1.0 Hz), 43.8.
2-ylboronic acid and thiophen-3-ylboronic acid were employed as
coupling partners to obtain the desired products 3m and 3n in 85
and 81% yields, respectively. In addition, the coupling reaction
of butylboronic acid also provided coupling product 3o in 42%
yield. Furthermore, the cross-coupling reaction of 5,6-dichloro-
1H-indene-1,3(2H)-dione monotosylhydrazone also provided
the desired products 3p and 3q in good yields. Usefully, the
reductive cross-coupling of N-tosylhydrazones 1a (4 mmol) with
phenylboronic acids (6 mmol) could be scaled up to gram-scale,
affording the desired product 3a in 87% yield (entry 17).
3-(4-(Trifluoromethyl)phenyl)-2,3-dihydro-1H-inden-1-one (3f):44
Light-yellow solid; m.p. 73.2–75.4 °C [lit.44 84–85 °C]; 1H NMR
(400 MHz, CDCl3): δ 7.84 (d, J = 7.7 Hz, 1H), 7.65–7.53 (m, 3H),
7.45 (t, J = 7.5 Hz, 1H), 7.25 (d, J = 7.7 Hz, 3H), 4.66 (dd, J = 8.2, 3.9
Hz, 1H), 3.26 (dd, J = 19.2, 8.1 Hz, 1H), 2.66 (dd, J = 19.2, 3.9 Hz,
1H); 13C NMR (100 MHz, CDCl3): δ 205.1, 156.8, 147.7 (q, J = 1.4
Hz), 136.8, 135.3, 129.4 (q, J = 32.5 Hz), 128.3, 128.0, 126.7, 125.9 (q,
J = 3.8 Hz), 124.0 (q, J = 271.0 Hz), 123.65, 46.5, 44.2.
Experimental
NMR spectra were obtained on a Bruker DPX-400 spectrometer
(1H NMR at 400 Hz, 13C NMR at 100 Hz) in CDCl3 using TMS as
internal reference. Chemical shifts (δ) are given in parts per million
(ppm) and coupling constants (J) are given in Hz. EI–mass spectra
were measured on an LC/Q–TOF MS (Micromass, England). All
products were isolated by short chromatography on a silica gel
(200–300 mesh) column using petroleum ether (60–90 °C). Unless
otherwise noted, 1,3-indanedione and its derivatives, arylboronic
acids, and bases and solvents of analytical grade quality were
purchased from Adamas-beta Pharmaceuticals, Inc.
4-(3-Oxo-2,3-dihydro-1H-inden-1-yl)benzonitrile (3g):46 Light-
1
yellow oil; H NMR (400 MHz, CDCl3): δ 7.84 (d, J = 7.7 Hz, 1H),
7.67–7.57 (m, 3H), 7.47 (t, J = 7.5 Hz, 1H), 7.34–7.17 (m, 3H), 4.65 (dd,
J = 8.2, 3.8 Hz, 1H), 3.27 (dd, J = 19.2, 8.2 Hz, 1H), 2.64 (dd, J = 19.2,
3.8 Hz, 1H);13C NMR (100 MHz, CDCl3): δ 204.7, 156.3, 149.2, 136.8,
135.4, 132.8, 128.5, 128.5, 126.7, 123.8, 111.1, 46.3, 44.4.
Ethyl
4-(3-oxo-2,3-dihydro-1H-inden-1-yl)benzoate
(3h):47
Light-yellow solid; m.p. 115.1–116.7 °C [lit.47 113–114 °C]; H NMR
(400 MHz, CDCl3): δ 7.99 (d, J = 8.4 Hz, 2H), 7.83 (d, J = 7.7 Hz,
1H), 7.58 (td, J = 7.5, 1.3 Hz, 1H), 7.44 (t, J = 7.5 Hz, 1H), 7.24 (dd,
J = 7.8, 0.9 Hz, 1H), 7.20 (d, J = 8.3 Hz, 2H), 4.64 (dd, J = 8.2, 3.9
Hz, 1H), 4.37 (q, J = 7.1 Hz, 2H), 3.26 (dd, J = 19.2, 8.1 Hz, 1H), 2.68
(dd, J = 19.2, 3.9 Hz, 1H), 1.38 (t, J = 7.1 Hz, 3H);13C NMR (100 MHz,
CDCl3): δ 205.3, 166.2, 157.1, 148.8, 136.8, 135.2, 130.2, 128.2, 127.6,
126.8, 123.6, 61.0, 46.5, 44.4, 14.3.
1
CsF-promoted coupling reaction of 1,3-indanedione monoto-
sylhydrazones and arylboronic acids; general procedure
A Schlenk tube (20 mL) was charged with a 1,3-indanedione
monotosylhydrazone (1) (0.5 mmol), an arylboronic acid (2)
(0.75 mmol), K2CO3 (0.75 mmol) and CsF (0.25 mmol). The tube
was degassed for 30 s and then filled with argon. This operation was
repeated three times. After 1,4-dioxane (5 mL) was added under an
argon atmosphere, the resulting reaction mixture was stirred at 110 °C
for 5 h. After the completion of the reaction, the reaction mixture
was allowed to cool to room temperature. Ethyl acetate (5 mL) and a
saturated solution of NaCl (5 mL) were added and the layers were
separated. The aqueous phase was extracted three times with ethyl
acetate (3 × 5 mL). The organic layer was then dried over anhydrous
MgSO4 and filtered and the solvent was removed under reduced
pressure. The crude mixture was purified by chromatography on silica
gel to yield the desired products.
3-(4-Vinylphenyl)-2,3-dihydro-1H-inden-1-one (3i): Light-yellow
1
oil; H NMR (400 MHz, CDCl3): δ 7.81 (d, J = 7.5 Hz, 1H), 7.57
(td, J = 7.5, 1.3 Hz, 1H), 7.42 (t, J = 7.4 Hz, 1H), 7.35 (d, J = 8.1 Hz,
2H), 7.26 (dd, J = 8.0, 1.2 Hz, 1H), 7.08 (d, J = 8.2 Hz, 2H), 6.69 (dd,
J = 17.6, 10.9 Hz, 1H), 5.72 (dd, J = 17.6, 0.9 Hz, 1H), 5.23 (dd, J = 10.9,
0.9 Hz, 1H), 4.57 (dd, J = 8.1, 3.9 Hz, 1H), 3.23 (dd, J = 19.2, 8.0 Hz,
1H), 2.68 (dd, J = 19.2, 3.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ
206.0, 157.9, 143.4, 136.9, 136.6, 136.4, 135.2, 128.0, 127.9, 127.0,
126.9, 123.6, 114.0, 46.9, 44.3; HRMS (ESI) m/z: Calcd for C17H15O+
(M+H)+: 235.11174; found: 235.11171.
3-(3-Chlorophenyl)-2,3-dihydro-1H-inden-1-one (3j):1 Light-yellow
3-Phenyl-2,3-dihydro-1H-inden-1-one (3a):43 Light-yellow oil;
1H NMR (400 MHz, CDCl3): δ 7.81 (d, J = 7.6 Hz, 1H), 7.57 (td, J = 7.4,
1.3 Hz, 1H), 7.47–7.36 (m, 1H), 7.37–7.19 (m, 4H), 7.17–7.08 (m, 2H),
4.58 (dd, J = 8.0, 3.8 Hz, 1H), 3.23 (dd, J = 19.2, 8.1 Hz, 1H), 2.69 (dd,
J = 19.2, 3.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 205.9, 157.9,
143.6, 136.7, 135.0, 128.9, 127.8, 127.6, 126.9, 126.9, 123.4, 46.8, 44.4.
3-(p-Tolyl)-2,3-dihydro-1H-inden-1-one (3b):42 Light-yellow oil;
1H NMR (400 MHz, CDCl3): δ 7.80 (dt, J = 7.7, 1.0 Hz, 1H), 7.55 (td,
J = 7.5, 1.3 Hz, 1H), 7.40 (t, J = 7.2 Hz, 1H), 7.26 (dd, J = 7.5, 0.8 Hz,
1H), 7.12 (d, J = 7.7 Hz, 2H), 7.01 (d, J = 8.1 Hz, 2H), 4.54 (dd, J = 8.0,
3.9 Hz, 1H), 3.21 (dd, J = 19.2, 8.0 Hz, 1H), 2.67 (dd, J = 19.2, 3.9 Hz,
1H), 2.32 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 206.3, 158.3, 140.8,
136.8, 136.7, 135.2, 129.7, 127.9, 127.6, 126.9, 123.5, 47.0, 44.2, 21.1.
3-(4-Methoxyphenyl)-2,3-dihydro-1H-inden-1-one (3c):43 Light-
1
oil; H NMR (400 MHz, CDCl3): δ 7.82 (d, J = 7.7 Hz, 1H), 7.59 (td,
J = 7.5, 1.3 Hz, 1H), 7.44 (t, J = 7.5 Hz, 1H), 7.27 (d, J = 6.8 Hz, 1H),
7.24–7.20 (m, 1H), 7.11 (s, 1H), 7.00 (dt, J = 6.4, 2.3 Hz, 1H), 4.56 (dd,
J = 8.1, 3.9 Hz, 1H), 3.23 (dd, J = 19.2, 8.1 Hz, 1H), 2.65 (dd, J = 19.2,
3.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 205.4, 157.1, 145.8, 136.9,
135.4, 134.8, 130.3, 128.3, 127.9, 127.3, 126.9, 125.9, 123.7, 46.7, 44.2.
3-(3,4-Dichlorophenyl)-2,3-dihydro-1H-inden-1-one (3k):46 Light-
yellow oil; 1H NMR (400 MHz, CDCl3): δ 7.83 (d, J = 7.7 Hz, 1H), 7.61
(td, J = 7.5, 1.3 Hz, 1H), 7.46 (t, J = 7.5 Hz, 1H), 7.38 (d, J = 8.2 Hz,
1H), 7.27 (d, J = 8.3 Hz, 1H), 7.23 (d, J = 2.1 Hz, 1H), 6.95 (dd, J = 8.3,
2.2 Hz, 1H), 4.55 (dd, J = 8.1, 3.9 Hz, 1H), 3.24 (dd, J = 19.3, 8.1 Hz,
1H), 2.63 (dd, J = 19.2, 3.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ
205.0, 156.6, 144.1, 136.8, 135.5, 133.0, 131.2, 131.0, 129.8, 128.5,
127.1, 126.8, 123.8, 46.6, 43.7.
1
yellow oil; H NMR (400 MHz, CDCl3): δ 7.80 (d, J = 7.6 Hz, 1H),
3-(3,4,5-Trifluorophenyl)-2,3-dihydro-1H-inden-1-one (3l): Light-
yellow solid; m.p. 111.6–112.2 °C; 1H NMR (400 MHz, CDCl3): δ 7.83
(d, J = 7.7 Hz, 1H), 7.63 (td, J = 7.5, 1.3 Hz, 1H), 7.48 (t, J = 7.5 Hz, 1H),
7.28 (dd, J = 7.7, 0.9 Hz, 1H), 6.75 (dd, J = 8.4, 6.4 Hz, 2H), 4.54 (dd,
J = 8.2, 3.9 Hz, 1H), 3.23 (dd, J = 19.2, 8.2 Hz, 1H), 2.59 (dd, J = 19.1,
3.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 204.5, 156.0, 151.5 (ddd,
J = 251.0, 10.0, 4.1 Hz), 140.2 (td, J = 6.7, 4.6 Hz), 138.9 (dt, J = 250.0,
15.3 Hz), 136.9, 135.6, 128.7, 126.8, 123.9, 111.7 (dd, J = 15.6, 5.7 Hz),
46.5, 43.8; 19F NMR (376 MHz, CDCl3): δ −133.3, −162.3 (t, J = 20.6
Hz); HRMS (ESI) m/z: Calcd for C15H10F3O+ (M+H)+: 263.06783;
found: 263.06784.
7.56 (td, J = 7.6, 1.3 Hz, 1H), 7.40 (t, J = 7.5 Hz, 1H), 7.26 (dd, J = 7.7,
0.9 Hz, 1H), 7.04 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 4.53 (dd,
J = 8.0, 3.9 Hz, 1H), 3.79 (s, 3H), 3.21 (dd, J = 19.2, 8.0 Hz, 1H), 2.65 (dd,
J = 19.2, 3.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 206.3, 158.7, 158.4,
136.8, 135.9, 135.2, 128.7, 127.9, 126.9, 123.4, 114.4, 55.4, 47.1, 43.8.
3-(4-Bromophenyl)-2,3-dihydro-1H-inden-1-one (3d):42 Light-
1
yellow oil; H NMR (400 MHz, CDCl3): δ 7.81 (d, J = 7.7 Hz, 1H),
7.58 (td, J = 7.6, 1.2 Hz, 1H), 7.48–7.37 (m, 3H), 7.25 (dd, J = 7.7, 0.9
Hz, 1H), 7.00 (d, J = 8.4 Hz, 2H), 4.55 (dd, J = 8.1, 3.9 Hz, 1H), 3.23
(dd, J = 19.2, 8.1 Hz, 1H), 2.63 (dd, J = 19.2, 3.9 Hz, 1H); 13C NMR
(100 MHz, CDCl3): δ 205.5, 157.3, 142.9, 136.9, 132.1, 129.5, 128.2,
126.9, 121.0, 46.8, 44.0.
3-(Naphthalen-2-yl)-2,3-dihydro-1H-inden-1-one (3m):43 Light-
1
3-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-one (3e):43 Light-
yellow oil; 1H NMR (400 MHz, CDCl3): δ 7.81 (d, J = 7.7 Hz, 1H), 7.58
yellow oil; H NMR (400 MHz, CDCl3): δ 7.85 (d, J = 7.7 Hz, 1H),
7.85–7.74 (m, 3H), 7.66 (d, J = 1.7 Hz, 1H), 7.57 (td, J = 7.5, 1.3 Hz, 1H),